Latest Articlesddd
Juno Therapeutics (JUNO) is due to receive a fee payment of $50 million from Celgene. The reason …
Regeneron and Intellia to Discover and Develop CRISPR/Cas Therapeutics Moving forward is Regeneron Pharmaceuticals’ (REGN) strategy based on strong …
Dealing With Bacterial Resistance To Antibiotics In the NEWS THERAVANCE BIOPHARMA At the 26th European Congress …
Another day, another badly needed treatment for a dangerous disease is on its way to be …
Years ago, a friend who is a highly regarded Immunologist lectured us during one of our …
Pfizer (PF) terminated its acquisition agreement with Allergan Plc (AGN) The new set of rules released by …
PFIZER Pfizer (PF) announced that its oral drug tofacitinib in doses of 5 mg and 10 mg …
Prohost Letter #394 Part 2 PART 2 - Part 1 of the Prohost letter issue #394 posted …
Many in Wall Street have been anxious, sitting on fire while waiting to learn, which biotech …
Prohost Letter #394 Part 1 Gilead - Some people sold Gilead’s (GILD) stock on Wednesday, March 23 …
Incyte (INCY) and Eli Lilly (LLY): The New England Journal of Medicine published detailed results of RA-BEACON — a pivotal …
The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) voted 12 to 2 …
Alder Reports Phase 2b Trial of ALD403 Meets Primary and Secondary Endpoints Demonstrating Migraine Prevention in …
It is an ingenuous decision made by investors who rushed to consider betrixaban Phase 3 APEX study a …
Amgen (AMGN) and UCB (Euronext Brussels: UCB) announced positive results from the BRIDGE pivotal Phase 3 placebo-controlled …
Published articles in peer review journals cited that pharmacologic inhibition of RORγt regulates Th17 signature gene expression …
Immunotherapy for Cancer Blueprint Medicines Blueprint Medicines (BPMC) entered into a worldwide collaboration and exclusive license agreement …
First therapy to demonstrate statistically significant improvement in overall survival and induction response rate in a …
London, UK, 14 March 2016: GW Pharmaceuticals (GWPH), is a biopharmaceutical company focused on discovering, developing and …
The Diagnosed Dead Is Far from Dying Xoma (XOMA): Stock rallied following report announcing an upfront …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
